Treatment of resistant pain in hypertrophic pulmonary osteoarthropathy with subcutaneous octreotide.
Pain in hypertrophic pulmonary osteoarthropathy (HPOA) due to periostitis and arthropathy can be a particularly disabling symptom, and resistant to a wide variety of treatments. The effectiveness of subcutaneous octreotide in relieving this pain in a patient with HPOA is reported.
Johnson
S A
SA
St Mary's Hospice, Selly Park, Birmingham, UK.
Spiller
P A
PA
Faull
C M
CM
D001984:Bronchial Neoplasms / Q000150:complications; D002294:Carcinoma, Squamous Cell / Q000150:complications; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage* / Q000627:therapeutic use; D010005:Osteoarthropathy, Secondary Hypertrophic / Q000188:drug therapy* / Q000209:etiology; D010146:Pain / Q000188:drug therapy / Q000209:etiology
D006728:Hormones; D015282:Octreotide